BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16905695)

  • 41. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiofrequency ablation of Barrett's esophagus: short-term results.
    Eldaif SM; Lin E; Singh KA; Force SD; Miller DL
    Ann Thorac Surg; 2009 Feb; 87(2):405-10; discussion 410-1. PubMed ID: 19161747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
    Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up.
    Sharma P; Jaffe PE; Bhattacharyya A; Sampliner RE
    Gastrointest Endosc; 1999 Apr; 49(4 Pt 1):442-6. PubMed ID: 10202056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
    Globe J; Smythe A; Kelty CJ; Reed MW; Brown NJ; Ackroyd R
    J Photochem Photobiol B; 2006 Oct; 85(1):17-22. PubMed ID: 16723253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
    O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
    Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.
    Bright T; Watson DI; Tam W; Game PA; Ackroyd R; Devitt PG; Schoeman MN
    Dig Dis Sci; 2009 Dec; 54(12):2606-11. PubMed ID: 19101798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection.
    Anders M; Bähr C; El-Masry MA; Marx AH; Koch M; Seewald S; Schachschal G; Adler A; Soehendra N; Izbicki J; Neuhaus P; Pohl H; Rösch T
    Gut; 2014 Oct; 63(10):1535-43. PubMed ID: 24389236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Barrett esophagus with severe dysplasia in argon beam therapy].
    Maass S; Martin WR; Spiethoff A; Riemann JF
    Z Gastroenterol; 1998 Apr; 36(4):301-6. PubMed ID: 9612928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
    Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
    Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
    Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
    Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Argon plasma coagulation ablation of Barrett's oesophagus.
    Claydon PE; Ackroyd R
    Scand J Gastroenterol; 2005 Jun; 40(6):617-28. PubMed ID: 16036520
    [No Abstract]   [Full Text] [Related]  

  • 58. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.
    Fass R; Garewal HS; Hayden CW; Ramsey L; Sampliner RE
    Gastrointest Endosc; 2001 Jun; 53(7):711-6. PubMed ID: 11375576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermal ablation of Barrett's esophagus: a heated debate.
    Spechler SJ
    Am J Gastroenterol; 2006 Aug; 101(8):1770-2. PubMed ID: 16928252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.